CN Patent

CN117529321A — Erk抑制剂和kras抑制剂的组合及其用途

Assigned to Shanghai Deqi Pharmaceutical Technology Co ltd · Expires 2024-02-06 · 2y expired

What this patent protects

本公开总体上涉及ERK抑制剂和KRAS抑制剂的组合及其用途。

USPTO Abstract

本公开总体上涉及ERK抑制剂和KRAS抑制剂的组合及其用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN117529321A
Jurisdiction
CN
Classification
—
Expires
2024-02-06
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Deqi Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.